An essential role for Gα(i2) in Smoothened-stimulated epithelial cell proliferation in the mammary gland

• Published in: Science signaling 2015-09, Vol.8 (394), p.ra92-ra92
• Main Authors: Villanueva, Hugo, Visbal, Adriana P, Obeid, Nadine F, Ta, Andrew Q, Faruki, Adeel A, Wu, Meng-Fen, Hilsenbeck, Susan G, Shaw, Chad A, Yu, Peng, Plummer, Nicholas W, Birnbaumer, Lutz, Lewis, Michael T
• Format: Article
• Language: English
• Subjects: Animals; Cell Proliferation - physiology; Drosophila; Epithelial Cells - cytology; Epithelial Cells - metabolism; Female; GTP-Binding Protein alpha Subunit, Gi2 - genetics; GTP-Binding Protein alpha Subunit, Gi2 - metabolism; Humans; Mammary Glands, Animal - cytology; Mammary Glands, Animal - metabolism; Mice; Mice, Transgenic; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; Signal Transduction - physiology; Smoothened Receptor
• ISSN: 1937-9145
• DOI: 10.1126/scisignal.aaa7355

Hedgehog (Hh) signaling is critical for organogenesis, tissue homeostasis, and stem cell maintenance. The gene encoding Smoothened (SMO), the primary effector of Hh signaling, is expressed aberrantly in human breast cancer, as well as in other cancers. In mice that express a constitutively active form of SMO that does not require Hh stimulation in mammary glands, the cells near the transgenic cells proliferate and participate in hyperplasia formation. Although SMO is a seven-transmembrane receptor like G protein-coupled receptors (GPCRs), SMO-mediated activation of the Gli family of transcription factors is not known to involve G proteins. However, data from Drosophila and mammalian cell lines indicate that SMO functions as a GPCR that couples to heterotrimeric G proteins of the pertussis toxin (PTX)-sensitive Gαi class. Using genetically modified mice, we demonstrated that SMO signaling through G proteins occurred in the mammary gland in vivo. SMO-induced stimulation of proliferation was PTX-sensitive and required Gαi2, but not Gαi1, Gαi3, or activation of Gli1 or Gli2. Our findings show that activated SMO functions as a GPCR to stimulate proliferation in vivo, a finding that may have clinical importance because most SMO-targeted agents have been selected based largely on their ability to block Gli-mediated transcription.